Apatinib for Resectable Colorectal Cancer

NCT03228043 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER_GOV

Sponsor class

Stopped It's not possible to complete in our hospital.

Conditions

Apatinib
Outcome, Fatal
Colorectal Cancer
Surgery
Adjuvant Chemotherapy

Interventions

DRUG: Apatinib
DRUG: CAPEOX

Sponsor

Nanchong Central Hospital